Arthritis Drug Shows Promise In Clinical Trial
A clinical trial of masitinib, a drug in development for the treatment of rheumatoid arthritis, has shown it to be well tolerated and effective. Researchers writing in BioMed Central’s open access journal Arthritis Research and Therapy have shown that treatment with masitinib significantly reduced the severity of active arthritis.
More: continued here
Filed under: Arthritis on June 29th, 2009
You must be logged in to post a comment.